Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3866061 | The Journal of Urology | 2010 | 5 Pages |
Abstract
Topical clobetasol propionate used twice daily for clinical treatment of phimosis does not affect the hypothalamus-pituitary-adrenal axis in most patients. However, salivary cortisol level should be considered as a laboratory marker in long-term treatment or during repeated cycles to detect possible hypothalamus-pituitary-adrenal axis suppression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
F.O. Pileggi, C.E. Jr., M.F.G.S. Tazima, J.C. Daneluzzi, Y.A.M.V.A. Vicente,